Abstract
Aim and Objective: Cancer is one of the serious diseases that cause several human deaths every year. Up to now, we have spent lots of time and money to investigate this disease, thereby designing effective treatments. Previous studies mainly focus on studying genetic background of different subtypes of cancer and neglect another important factor, i.e. environmental factor. Carcinogenic chemical is one of the types of environmental factor; the exposure of such chemical may definitely initiate and promote the tumorigenesis. In this study, we tried to partly describe the differences between carcinogenic and non-carcinogenic chemicals using gene ontology (GO) terms and KEGG pathways.
Material and Methods: The carcinogenic and non-carcinogenic chemicals that were retrieved from Carcinogenic Potency Database (CPDB) were encoded into numeric vectors using the enrichment theories of GO terms and KEGG pathways. Then, the minimal redundancy maximal relevance (mRMR) method was adopted to analyze all the features, resulting in some important GO terms and KEGG pathways.
Results and Conclusion: The extensive analysis of the identified GO terms and KEGG pathways indicates that they all play roles during tumorigenesis, inducing that they can be the key indicator for the identification of carcinogenic chemicals.
Keywords: Carcinogenic chemical, non-carcinogenic chemical, enrichment score, GO term, KEGG pathway, minimal redundancy maximal relevance.
Combinatorial Chemistry & High Throughput Screening
Title:Analysis of Key GO Terms and KEGG Pathways Associated with Carcinogenic Chemicals
Volume: 20 Issue: 10
Author(s): Jing Ding and Ying Zhang*
Affiliation:
- Center for Certification and Evaluation, Shanghai Municipal Food and Drug Administration, Shanghai 200020,China
Keywords: Carcinogenic chemical, non-carcinogenic chemical, enrichment score, GO term, KEGG pathway, minimal redundancy maximal relevance.
Abstract: Aim and Objective: Cancer is one of the serious diseases that cause several human deaths every year. Up to now, we have spent lots of time and money to investigate this disease, thereby designing effective treatments. Previous studies mainly focus on studying genetic background of different subtypes of cancer and neglect another important factor, i.e. environmental factor. Carcinogenic chemical is one of the types of environmental factor; the exposure of such chemical may definitely initiate and promote the tumorigenesis. In this study, we tried to partly describe the differences between carcinogenic and non-carcinogenic chemicals using gene ontology (GO) terms and KEGG pathways.
Material and Methods: The carcinogenic and non-carcinogenic chemicals that were retrieved from Carcinogenic Potency Database (CPDB) were encoded into numeric vectors using the enrichment theories of GO terms and KEGG pathways. Then, the minimal redundancy maximal relevance (mRMR) method was adopted to analyze all the features, resulting in some important GO terms and KEGG pathways.
Results and Conclusion: The extensive analysis of the identified GO terms and KEGG pathways indicates that they all play roles during tumorigenesis, inducing that they can be the key indicator for the identification of carcinogenic chemicals.
Export Options
About this article
Cite this article as:
Ding Jing and Zhang Ying *, Analysis of Key GO Terms and KEGG Pathways Associated with Carcinogenic Chemicals, Combinatorial Chemistry & High Throughput Screening 2017; 20 (10) . https://dx.doi.org/10.2174/1386207321666171218120133
DOI https://dx.doi.org/10.2174/1386207321666171218120133 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Artificial Intelligence Methods for Biomedical, Biochemical and Bioinformatics Problems
Recently, a large number of technologies based on artificial intelligence have been developed and applied to solve a diverse range of problems in the areas of biomedical, biochemical and bioinformatics problems. By utilizing powerful computing resources and massive amounts of data, methods based on artificial intelligence can significantly improve the ...read more
Eco-friendly Agents for Biological Control of Pathogenic Diseases
The discovery of an alternative biological approach to disease management includes work on medicinal products derived from natural sources as a starting point for the development of eco-friendly agents for these diseases and the injuries they cause, as well as reducing human contact with hazardous chemicals and their residues. We ...read more
Emerging trends in diseases mechanisms, noble drug targets and therapeutic strategies: focus on immunological and inflammatory disorders
Recently infectious and inflammatory diseases have been a key concern worldwide due to tremendous morbidity and mortality world Wide. Recent, nCOVID-9 pandemic is a good example for the emerging infectious disease outbreak. The world is facing many emerging and re-emerging diseases out breaks at present however, there is huge lack ...read more
Exploring Spectral Graph Theory in Combinatorial Chemistry
Scope of the Thematic Issue: Combinatorial chemistry involves the synthesis and analysis of a large number of diverse compounds simultaneously. Traditional methods rely on brute force experimentation, which can be time-consuming and resource-intensive. Spectral Graph Theory, a branch of mathematics dealing with the properties of graphs in relation to the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Insight into p95HER2 in Breast Cancer: Molecular Mechanisms and Targeted Therapies
Recent Patents on DNA & Gene Sequences New Therapies for Prostate Cancer Based on the Biology of Androgen Receptor Coregulators
Current Cancer Therapy Reviews Natural Products and Cancer Stem Cells
Current Pharmaceutical Design Meet the Editorial Board:
Protein & Peptide Letters Heterologous Production of Death Ligands’ and Death Receptors’ Extracellular Domains: Structural Features and Efficient Systems
Protein & Peptide Letters The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors
Recent Patents on Anti-Cancer Drug Discovery Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent
Current Cancer Drug Targets Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges
Current Medicinal Chemistry Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study
Anti-Cancer Agents in Medicinal Chemistry Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
Current Cancer Drug Targets Never Sleep with Baby? Or Keep Me Close But Keep Me Safe: Eliminating Inappropriate “Safe Infant Sleep” Rhetoric in the United States
Current Pediatric Reviews Monitoring of Treatment-Induced Apoptosis in Oncology with PET and SPECT
Current Pharmaceutical Design Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development
Current Cancer Drug Targets Targeting Angiogenic Genes as a Therapeutic Approach for Hepatocellular Carcinoma
Current Gene Therapy Sugar Based Biopolymers in Nanomedicine; New Emerging Era for Cancer Imaging and Therapy
Current Topics in Medicinal Chemistry Locked Nucleic Acid Holds Promise in the Treatment of Cancer
Current Pharmaceutical Design Advances and Perspectives in Cell-Specific Aptamers
Current Pharmaceutical Design EZH2 RIP-seq Identifies Tissue-specific Long Non-coding RNAs
Current Gene Therapy Performance Analysis of Feature-Based Lung Tumor Detection and Classification
Current Medical Imaging Cancer Imaging Agents for Positron Emission Tomography: Beyond FDG
Current Medical Imaging